These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 15586356
21. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial. Benoehr P, Krueth P, Bokemeyer C, Grenz A, Osswald H, Hartmann JT. J Am Soc Nephrol; 2005 Feb; 16(2):452-8. PubMed ID: 15590762 [Abstract] [Full Text] [Related]
23. Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors. Lagrange JL, Médecin B, Etienne MC, Pivot X, Cassuto-Viguier E, Renée N, Thyss A, Ferrero JM, Otto J, François E, Milano G. Pharmacotherapy; 1997 Nov; 17(6):1246-53. PubMed ID: 9399607 [Abstract] [Full Text] [Related]
24. Renal function in pediatric liver transplantation: a long-term follow-up study. Harambat J, Ranchin B, Dubourg L, Liutkus A, Hadj-Haïssa A, Rivet C, Boillot O, Lachaux A, Cochat P. Transplantation; 2008 Oct 27; 86(8):1028-34. PubMed ID: 18946339 [Abstract] [Full Text] [Related]
25. Long-term follow-up of renal function after high-dose methotrexate treatment in children. Grönroos MH, Jahnukainen T, Möttönen M, Perkkiö M, Irjala K, Salmi TT. Pediatr Blood Cancer; 2008 Oct 27; 51(4):535-9. PubMed ID: 18523995 [Abstract] [Full Text] [Related]
26. [Late effect of treatment of nephroblastoma in patients treated in 1980-2001 in a single centre]. Radvanský J, Slabý K, Radvanská J, Malis J, Eckschalger T, Sulc J, Safárová M, Kolský A, Procházka M, Gilík J. Klin Onkol; 2010 Oct 27; 23(4):245-55. PubMed ID: 20806823 [Abstract] [Full Text] [Related]
27. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647 [Abstract] [Full Text] [Related]
28. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
29. Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin. La Manna G, Virzì S, Deraco M, Capelli I, Accorsi A, Dalmastri V, Comai G, Bonomi S, Grassi A, Selva S, Feliciangeli G, Scolari M, Stefoni S. In Vivo; 2006 Mar 15; 20(6A):703-6. PubMed ID: 17203749 [Abstract] [Full Text] [Related]
30. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD. Nephrol Dial Transplant; 2008 Feb 15; 23(2):573-9. PubMed ID: 17984104 [Abstract] [Full Text] [Related]
31. Renal function outcome in pediatric liver transplant recipients. Mention K, Lahoche-Manucci A, Bonnevalle M, Pruvot FR, Declerck N, Foulard M, Gottrand F. Pediatr Transplant; 2005 Apr 15; 9(2):201-7. PubMed ID: 15787794 [Abstract] [Full Text] [Related]
32. The natural history of renal function following orthotopic heart transplant. Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B. Clin Transplant; 2005 Oct 15; 19(5):683-9. PubMed ID: 16146562 [Abstract] [Full Text] [Related]
33. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM, Mauer M, International Diabetic Nephropathy Study Group. Pediatr Endocrinol Rev; 2008 Aug 15; 5 Suppl 4():958-63. PubMed ID: 18806710 [Abstract] [Full Text] [Related]
34. Prognostic impact of moderate renal dysfunction in acute coronary syndromes. Nabais S, Rocha S, João C, Marques J, Torres M, Magalhães S, Pereira MA, Correia A. Rev Port Cardiol; 2008 Mar 15; 27(3):303-12; discussion 315-7. PubMed ID: 18551917 [Abstract] [Full Text] [Related]
35. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN. Biol Blood Marrow Transplant; 2009 Oct 15; 15(10):1251-7. PubMed ID: 19747632 [Abstract] [Full Text] [Related]
36. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. Hailpern SM, Cohen HW, Alderman MH. Am J Hypertens; 2006 Oct 15; 19(10):998-1004. PubMed ID: 17027817 [Abstract] [Full Text] [Related]
37. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J. Pediatr Blood Cancer; 2006 Jul 15; 47(1):83-8. PubMed ID: 16317732 [Abstract] [Full Text] [Related]
38. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach. Orgel E, Jain S, Ji L, Pollick L, Si S, Finlay J, Freyer DR. Pediatr Blood Cancer; 2012 Jun 15; 58(6):953-8. PubMed ID: 21796767 [Abstract] [Full Text] [Related]
39. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients]. Grabysa R, Cholewa M. Pol Merkur Lekarski; 2008 Jun 15; 24(144):487-91. PubMed ID: 18702327 [Abstract] [Full Text] [Related]
40. [The kidney in children under chemotherapy]. Cachat F, Guignard JP. Rev Med Suisse Romande; 1996 Dec 15; 116(12):985-93. PubMed ID: 9026889 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]